New York Seeks the “Select Experts” for Its Rare Disease Advisory Council: Rare Voices, Rare Seats
National Organization for Rare Disorders (NORD) recently shared an inviting post to Rare Disease Advisory Council on X:
”Join the New York State Rare Disease Advisory Council!
Are you a healthcare professional, researcher, caregiver, patient, or advocate passionate about Rare Diseases? New York State is establishing the Rare Disease Advisory Council to continue the important work launched by the Rare Disease Workgroup under Article 27-L of the Public Health Law (2021).
We’re looking for individuals from across New York to bring diverse perspectives and lived experiences to this effort. Help shape policies that support and elevate the voices of New Yorkers impacted by rare diseases.”
To submit your application, follow the link.
Calling all healthcare professionals, researchers, caregivers, and patients — if your connection to rare diseases puts you in that unique minority, New York wants you to join its newly formed Rare Disease Advisory Council.
Built on the foundations of Article 27-L of the Public Health Law, this council promises to elevate patient voices — assuming they can squeeze into policy meetings.
Applications now open for those ready to shape big decisions in small, infrequent doses!

To not miss opportunities in the field of your expertise, read Hemostasis Today, daily!
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
